This review summarizes the potential of marine-derived protein kinase inhibitors in the field of neuroinflammatory diseases, such as Parkinson disease, Alzheimer disease, multiple sclerosis, and pain. The gene discussed is WEE1; the disease is early-onset autosomal dominant Alzheimer disease.